Background-A study was performed to measure the quality of life of patients receiving home parenteral nutrition (HPN) 
for many years and one of the main aims of treatment must be to give the recipient the "best possible" quality of life. Assessments of quality of life using validated techniques have rarely been performed on this population of patients in the past.2 3 Information on outcomes is one of the central facets of the United Kingdom Health Technology Assessment Programme and this study was performed to measure one of the outcomes of HPN.
The aim of this study was to describe a profile of health status of patients on the HPN programme, employing commonly used, well validated, subjective health status instruments and to examine which factors moderated outcomes.
Methods

Patients
The patients studied were monitored by the University of Manchester intestinal failure unit, based at Hope Hospital, Salford. At the time of the study, 64 patients were receiving TPN at home. The average age was 44-4 (range 17-70) years; 40 (62-5%) were women. All patients had intestinal failure secondary to benign disease. The commonest underlying diagnosis was Crohn's disease (n=35, 550/o) followed by mesenteric vessel occlusion (n= 1 1, 17%), and volvulus (n=8, 12-5%). The other patients had various diagnoses (n= 10, 15 * 5%). All had received at least six months of nutrition at home. The median duration of HPN treatment was four (range 0-5-15) years. The HPN was infused on a cyclical nocturnal basis in 63 (98%) patients for a median of six (range 2-7) nights. All patients were treated according to standard unit protocols. We utility scores which are equivalent to a single score for health status on a scale of zero to one (O=death, 1 =best possible quality of life). The domains covered by EuroQol are also relevant to the HPN population and include mobility, self care, activity, pain, and mental wellbeing. Self rated health status (scale O=death, 100=best possible quality of life) and change in health status over the past 12 months are also recorded. Both questionnaires can be completed in less than 15 minutes, making them a suitable combination for postal distribution. Written reminders were sent to nonrespondents after four weeks.
The SF 36 questionnaires were scored according to the published scoring manual. 6 EuroQol health states were valued according to the scoring sheet and self rated health states were compared with population "norms" (available from members of the EuroQol Group). We retested 10 patients (16%) in the outpatient clinic to assess the reproducibility of the results. Before starting the study we calculated that 34 patients were required to make statistical inferences.7 The Mann-Witney U test was used to determine significance.
Results
Fifty one (of 64) completed questionnaires were received. Forty one (80%) patients reported that they were too ill to work. Only five (10%) were in full or part time work or study and five (10%) were able to cope with housework alone . Tables II and III show the mean SF 36 and EuroQol scores. The scores for physical function, physical role, emotional role, social function, vitality, and pain were all significantly lower than normal population scores (Table II) . Emotional role and mental health scores were at the lower end of the normal range. No differences were seen between the patients who said that they were too ill to work and those who were in employment although small numbers in the employed group prevented meaningful analysis. The scores for the younger patients (age <45) were good (Fig 1), and lower scores (p<0.05) in the domains of physical functioning, social functioning, and emotional role (Fig 1) . (Fig 3) (Fig 4) . Scores Price et al1I examined early responses to HPN and reported that feelings of anger, anxiety and depression result from the sense of loss sustained by the patient. The loss includes the inability to eat normally, loss of independence, loss of social and work status, and loss of control of bodily functions. Price also reported that the premorbid psychological and physical profile of the patient also has a bearing on the quality of life achieved. The psychological problems that are encountered on HPN tend to disperse as the new way of life becomes accepted' and the end result depends on the level to which their physical health is restored. 11 Sexual functioning decreases in most patients and only the occasional patient notices an improvement.11 Sexual functioning among younger patients was reported as normal; however, it had ceased completely in some of the patients over 55 years of age. 9 Burnes et al in did not find that older patients had a worse quality of life than the young, but in the cohort studied by O'Hanrahan and Irving,'0 older patients did less well. Herfindal et al3 measured life satisfaction scores of HPN recipients and found them to be in the upper two thirds of the index range; however, these scores were significantly lower than those obtained bv patients with end stage renal disease and the general population.
Patients with severe Crohn's disease have usuallv come to terms with limitations in their lifestyle and often note an improvement in quality of life when started on HPN. This contrasts greatly with those who have a mesenteric vessel occlusion. Often well before their illness, they find their new circumstances quite devastating. 3 The return to employment is often made on a part time basis as many patients find that thev are unable to cope with their previous workload.' 1 16 This studv has attempted to improve and update the existing evidence.
The results indicate that the patients have, on average, a fairly good quality of life. On the basis that the alternative of not treating these patients is usuallv death, then the treatment option would seem to be acceptable. This is particularly the case with younger patients, who can usuallv be restored to a near normal quality of life.
The older patients in our study had significantly lower quality of life scores compared with their younger counterparts. It is anticipated that our aging population of patients on HPN will pose a future management problem as they become less able to manage the complex aseptic procedure. We have evidence that this age group has a higher incidence of catheter infections1 combined with a lower quality of life.
Patients with Crohn's disease receiving HPN had scores that were no different from the other disease subgroups, but small numbers in the subgroups prevented statistical confirmation of this fact.
We have a fairly high proportion of patients addicted to opiate analgesics (16%) and scores from five of those who responded were very low. Clinical outcomes for this subgroup are also poor. 18 The percentage of recipients of HPN who were employed at the time of this survey (5%) was much lower than previously reported (52%) in a similar cohort of patients.'3 The reason for this is unclear but it may be a result of illness related financial benefits.
These results are for a cohort ofpatients with benign intestinal failure. We do not have any patients with AIDS or active cancer and therefore our results cannot be extended to these groups. The main aim of using HPN for terminal malignant disease must be to improve the quality of life, and to get the patient home. The evidence of efficacy of HPN for these patients is almost non-existent at present and in particular no quality of life data for these patients could be located. This, combined with the dismal survival statistics'6 indicates an urgent need for an assessment of effectiveness and a comparison with alternative therapeutic strategies.
The technology of HPN is lifesaving for most patients with benign intestinal failure and therefore some reduction in the quality of life is acceptable. When patients are being considered for HPN it is important to judge each case individually. Some consideration should be given to the outcomes that have been shown in the older age group, but this should not be a limiting factor if other aspects of the case are favourable. At present HPN remains the only long term option for the treatment of benign intestinal failure. 
